Aducanumab: A Deep Dive into BIIB037 and its Impact A drug, previously known as BIIB037, is a significant effort to combat mild Alzheimer's disease. Designed by Biogen, aducanumab functions by clearing amyloid deposits https://www.targetmol.com/compound/aducanumab